This site is intended for health professionals only
Monday 27 May 2019
Share |

Hep C targeted by Glaxo takeover

Fighting the hepatitis C virus (HCV) is the prime mover behind the $57 (£36m) million acquisition of Genelabs Technologies by GlaxoSmithKline (GSK).

GSK`s Zhi Hong said: "Genelabs has demonstrated a strong track record in HCV drug discovery and has identified numerous novel classes of inhibitors that target unprecedented mechanisms in the virus's life cycle.

"This arrangement will give GSK a broad HCV drug-discovery platform addressing novel targets and innovative therapeutic approaches."

The acquisition is hailed as continuing GSK's strategy of pursuing the best science, internally or externally, to bring new medicines to patients and value to the GSK pipeline.

There is an unmet need for new drugs to treat HCV infection. Currently the gold standard therapy comprises pegylated-alpha interferon (IFN) plus ribavirin (RBV) but the efficacy rate of this combination is relatively low and both drugs are associated with significant side effects that often lead to treatment discontinuation.

Several new antiviral drugs targeting multiple virus and host targets are currently in development. Rapidly-emerging drug resistance suggests that combination therapies with multiple classes of drugs will be required to achieve sustained virological response.

Copyright PA Business 2008

Genelabs Technologies

Ads by Google

You are leaving

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?


Respect for nurses: Sign up to our e-petition TODAY

The Nursing in Practice Respect campaign is now live! Over the coming months, we're set to highlight the vital contribution and efforts of primary care and community care nurses throughout the UK.

As part of our campaign, Nursing in Practice is looking to call on parliament to set up a debate to celebrate the vital work that you do.



Calling all primary care nurses! 'Like' our Nursing in Practice Facebook page to enter our free draw to win a £25 M&S voucher